CGTX
Cognition Therapeutics Inc
0.9366$
-0.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.5% | -12.1% | +15.5% | +4.5% | +1.4% | -36.6% | +35.6% | +0.0% | +0.0% | +11.5% | -19.1% | – | |
| – | +0.0% | +9.3% | -2.0% | -21.9% | -40.4% | +9.7% | +6.0% | -15.9% | -31.4% | -7.8% | -3.3% | – | |
| – | +7.3% | -68.9% | -135.2% | – | -154.0% | – | – | -404.0% | – | – | – | – | |
| – | -48.3% | -100.0% | – | +0.0% | -66.7% | -100.0% | – | – | – | – | – | – | |
| – | -48.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -79.2% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +5.4% | -39.5% | +1.7% | -65.8% | +80.5% | +52.7% | +2.7% | – | |
| – | – | +391.7% | -101.2% | – | +3,359.3% | -88.6% | -42.0% | +4,410.2% | -98.2% | -138.5% | – | – | |
| – | – | – | -229.2% | – | – | -386.2% | – | – | -110.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.